These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31903619)

  • 1. Drug-induced hypersensitivity syndrome by i.v. immunoglobulin administration for Kawasaki disease.
    Satake M; Kudo K; Masuda A; Onoyama S; Furuno K; Furue M
    J Dermatol; 2020 Mar; 47(3):e74-e75. PubMed ID: 31903619
    [No Abstract]   [Full Text] [Related]  

  • 2. Marked pleural effusion after i.v. immunoglobulin therapy for Kawasaki disease.
    Koizumi K; Hoshiai M; Toda T; Nakane T; Sugita K
    Pediatr Int; 2018 Mar; 60(3):307-308. PubMed ID: 29480538
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.
    Nakagawa M; Watanabe N; Okuno M; Kondo M; Okagawa H; Taga T
    Am J Hematol; 2000 Mar; 63(3):160-1. PubMed ID: 10679809
    [No Abstract]   [Full Text] [Related]  

  • 4. Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.
    Yokoyama K; Yoshida A
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30902846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aseptic meningitis secondary to intravenous immunoglobulin treatment in Kawasaki disease].
    García Norniella B; Morán Poladura M; Fernández Díaz M; Fernández Fernández E; Suárez Castañón C
    An Pediatr (Barc); 2011 Jul; 75(1):79-80. PubMed ID: 21420919
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y; Kamei A; Fujii Y; Ishikawa K; Chida S
    J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
    Lo MS; Newburger JW
    Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.
    Kuo HC; Wang CL; Wang L; Yu HR; Yang KD
    Pediatr Allergy Immunol; 2008 Mar; 19(2):184-5. PubMed ID: 18257906
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-dose intravenous immunoglobulin treatment].
    Nonaka Z
    Nihon Rinsho; 2008 Feb; 66(2):327-31. PubMed ID: 18260332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin resistance in Kawasaki disease with chronic granulomatous disease.
    Tsuge M; Shigemitsu Y; Yano Y; Fujiwara M; Miyai T; Ueda K; Takata K; Moriwake T
    Pediatr Int; 2012 Jun; 54(3):e32-4. PubMed ID: 22631588
    [No Abstract]   [Full Text] [Related]  

  • 12. Abducens nerve palsy in a girl with incomplete Kawasaki disease.
    Emiroglu M; Alkan G; Kartal A; Cimen D
    Rheumatol Int; 2016 Aug; 36(8):1181-3. PubMed ID: 27329470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin.
    Gordon DJ; Sloan SR; de Jong JL
    Am J Hematol; 2009 Nov; 84(11):771-2. PubMed ID: 19806664
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T; Inoue Y; Morikawa A
    Nihon Rinsho; 2008 Feb; 66(2):332-7. PubMed ID: 18260333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
    Pagnini I; Marino A; Simonini G; Cimaz R
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome.
    Boyce TG; Spearman P
    Pediatr Infect Dis J; 1998 Nov; 17(11):1054-6. PubMed ID: 9849996
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunoglobulin in suspected Kawasaki disease].
    García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L
    An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
    [No Abstract]   [Full Text] [Related]  

  • 18. Crystalline keratopathy due to intravenous immunoglobulin in a 12-year-old girl with Kawasaki disease.
    Viswanathan V; Agashe P; Jain V; Nair AG
    J AAPOS; 2016 Oct; 20(5):466-468.e1. PubMed ID: 27667371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A
    Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Deformation of Neutrophils in Kawasaki Disease.
    Koike Y; Yanagisawa R; Ogiso Y; Cho Y; Minami K; Takeuchi K; Sakashita K; Higuchi T
    J Pediatr; 2016 Jun; 173():238-241.e1. PubMed ID: 27039225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.